Cargando…
The potential of liquid biopsies for the early detection of cancer
Precision medicine refers to the choosing of targeted therapies based on genetic data. Due to the increasing availability of data from large-scale tumor genome sequencing projects, genome-driven oncology may have enormous potential to change the clinical management of patients with cancer. To this e...
Autores principales: | Heitzer, Ellen, Perakis, Samantha, Geigl, Jochen B., Speicher, Michael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871864/ https://www.ncbi.nlm.nih.gov/pubmed/29872715 http://dx.doi.org/10.1038/s41698-017-0039-5 |
Ejemplares similares
-
Circulating tumor cells and DNA as liquid biopsies
por: Heitzer, Ellen, et al.
Publicado: (2013) -
Emerging concepts in liquid biopsies
por: Perakis, Samantha, et al.
Publicado: (2017) -
Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide
por: Belic, Jelena, et al.
Publicado: (2018) -
Single circulating tumor cell sequencing for monitoring
por: Auer, Martina, et al.
Publicado: (2013) -
Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection
por: Ulz, Peter, et al.
Publicado: (2019)